Harry A. Drabkin - Concepedia

Author

Harry A. Drabkin

Also Known As

H A Drabkin, H Drabkin, H. A. Drabkin, H. Drabkin, H.A Drabkin, H.A. Drabkin, HARRY A. DRABKIN, HARRY DRABKIN, Harry A Drabkin, Harry A. Drabkin

261

Publications

13.8K

Citations

H-Index

119

Concepts

All Affiliations

University of Colorado Health University of Colorado Denver Medical University of South Carolina University of Colorado Cancer Center Roosevelt Institute

About

Harry A. Drabkin is an author at University of Colorado Health specializing in medicine, genetics, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	70	6.8K
2	Health Sciences	8	8	662
3	Natural Sciences	8	8	1.2K
4	Engineering	3	3	255
5	Social Sciences	1	1	41

Harry A. Drabkin

125

Publications

13.1K

Citations

H-Index

Page 1

	Year	Citations
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial Robert J. Motzer, Brian I. Rini, David F. McDermott, Journal of Clinical Oncology	2014	1.1K
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion Gilles David, Nacer Abbas, Giovanni Stévanin, Nature Genetics Sca7 GeneMolecular ResearchNatural SciencesGeneticsMolecular Biology	1997	769
Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma Bernd R. Seizinger, Guy A. Rouleau, Laurie J. Ozelius, Nature UrologyGenitourinary CancerRenal PathologyPathologyRenal Cell Carcinoma	1988	666
Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt Paul A. Erickson, J Gao, KS Chang, Blood	1992	574
Restoring E-Cadherin Expression Increases Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cell Lines Samir E. Witta, Robert M. Gemmill, Fred R. Hirsch, Cancer Research Tumor BiologyNsclc PrognosisOncologySignaling PathwayMedicine	2006	524
Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt Paul A. Erickson, J Gao, KS Chang, Blood	1992	502
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen, Investigational New Drugs UrologyPhase Ii TrialGenitourinary CancerMedicineAnti-cancer Agent	2013	399
Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer Ronald M. Bukowski, Fairooz F. Kabbinavar, Robert A. Figlin, Journal of Clinical Oncology	2007	312
High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non–Small-Cell Lung Cancer Roy M. Bremnes, Robert Veve, Edward Gabrielson, Journal of Clinical Oncology	2002	283
Cyclooxygenase-2–Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non–Small Cell Lung Cancer Mariam Dohadwala, Seok-Chul Yang, Jie Luo, Cancer Research Cancer BiologyTumor BiologyTranscriptional RegulationSignaling PathwayCell Regulation	2006	283

Page 1